These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 17721698)

  • 1. Adherence to clinical guidelines in the prevention of coronary heart disease in type II diabetes mellitus.
    Kamyar M; Johnson BJ; McAnaw JJ; Lemmens-Gruber R; Hudson SA
    Pharm World Sci; 2008 Jan; 30(1):120-7. PubMed ID: 17721698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of the MAT-CHDSP to assess guideline adherence and therapy goal achievement in secondary prevention of coronary heart disease after percutaneous coronary intervention.
    Garcia BH; Småbrekke L; Trovik T; Giverhaug T
    Eur J Clin Pharmacol; 2013 Mar; 69(3):703-9. PubMed ID: 22990329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary prevention in coronary heart disease: goal achievement and drug prescribing.
    Giverhaug T; Bruland C; Trovik T
    Pharm World Sci; 2005 Dec; 27(6):472-4. PubMed ID: 16341957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adherence to clinical guidelines in management of diabetes and prevention of cardiovascular disease in Qatar.
    Issam Diab M; Julienne Johnson B; Hudson S
    Int J Clin Pharm; 2013 Feb; 35(1):101-12. PubMed ID: 23135835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and validation of a medication assessment tool for cancer pain management.
    Håkonsen GD; Hudson S; Loennechen T
    Pharm World Sci; 2006 Dec; 28(6):342-51. PubMed ID: 17120130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal persistence with secondary prevention therapies relative to patient risk after myocardial infarction.
    Shore S; Jones PG; Maddox TM; Bradley SM; Stolker JM; Arnold SV; Parashar S; Peterson P; Bhatt DL; Spertus J; Ho PM
    Heart; 2015 May; 101(10):800-7. PubMed ID: 25801001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The need for pharmaceutical care in the prevention of coronary heart disease: an exploratory study in acute myocardial infarction patients.
    Chinwong S; Reid F; McGlynn S; Hudson S; Flapan A
    Pharm World Sci; 2004 Apr; 26(2):96-101. PubMed ID: 15085944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of cardiovascular medicines in newly treated type 2 diabetes patients: A retrospective cohort study in general practice.
    Grimes RT; Ensor J; Bennett K; Henman MC
    Prim Care Diabetes; 2016 Aug; 10(4):237-43. PubMed ID: 26654852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale and design of a randomized cluster trial to improve guideline-adherence of secondary preventive drugs prescription after coronary artery bypass grafting in China: Measurement and Improvement Studies of Surgical Coronary Revascularization: Secondary Prevention (MISSION-1) Study.
    Rao C; Du J; Li X; Li J; Zhang H; Zhao Y; Hu S; Jiang L; Zheng Z;
    Am Heart J; 2016 Aug; 178():9-18. PubMed ID: 27502847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MAT-CHDSP, a novel medication assessment tool for evaluation of secondary prevention of coronary heart disease.
    Garcia BH; Utnes J; Naalsund LU; Giverhaug T
    Pharmacoepidemiol Drug Saf; 2011 Mar; 20(3):249-57. PubMed ID: 21351306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An intervention to improve secondary prevention of coronary heart disease.
    Bailey TC; Noirot LA; Blickensderfer A; Rachmiel E; Schaiff R; Kessels A; Braverman A; Goldberg A; Waterman B; Dunagan WC
    Arch Intern Med; 2007 Mar; 167(6):586-90. PubMed ID: 17389290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence to guideline-recommended therapies among patients with diverse manifestations of vascular disease.
    Chen DC; Armstrong EJ; Singh GD; Amsterdam EA; Laird JR
    Vasc Health Risk Manag; 2015; 11():185-92. PubMed ID: 25767395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of adherence to international guidelines for treating patients with type 2 diabetes mellitus in Kuwait.
    Al-Taweel DM; Awad AI; Johnson BJ
    Int J Clin Pharm; 2013 Apr; 35(2):244-50. PubMed ID: 23254942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adding pharmacists to primary care teams increases guideline-concordant antiplatelet use in patients with type 2 diabetes: results from a randomized trial.
    Gilani F; Majumdar SR; Johnson JA; Tsuyuki RT; Lewanczuk RZ; Spooner R; Simpson SH
    Ann Pharmacother; 2013 Jan; 47(1):43-8. PubMed ID: 23324512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimizing prevention and guideline-concordant care in Montenegro.
    Knežević B; Musić L; Batrićević G; Bošković A; Bulatović N; Nenezić A; Vujović J; Kalezić M
    Int J Cardiol; 2016 Aug; 217 Suppl():S32-6. PubMed ID: 27381861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid lowering drug therapy in patients with coronary heart disease from 24 European countries--Findings from the EUROASPIRE IV survey.
    Reiner Ž; De Backer G; Fras Z; Kotseva K; Tokgözoglu L; Wood D; De Bacquer D;
    Atherosclerosis; 2016 Mar; 246():243-50. PubMed ID: 26812002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Primary prevention of coronary heart disease? What is cost effective in the clinical practice?].
    Kübler W
    Z Kardiol; 2005; 94 Suppl 3():III/92-9. PubMed ID: 16258799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the EuroObservational Research Programme of the European Society of Cardiology.
    Gyberg V; De Bacquer D; De Backer G; Jennings C; Kotseva K; Mellbin L; Schnell O; Tuomilehto J; Wood D; Rydén L; Amouyel P; Bruthans J; Conde AC; Cifkova R; Deckers JW; De Sutter J; Dilic M; Dolzhenko M; Erglis A; Fras Z; Gaita D; Gotcheva N; Goudevenos J; Heuschmann P; Laucevicius A; Lehto S; Lovic D; Miličić D; Moore D; Nicolaides E; Oganov R; Pająk A; Pogosova N; Reiner Z; Stagmo M; Störk S; Tokgözoğlu L; Vulic D;
    Cardiovasc Diabetol; 2015 Oct; 14():133. PubMed ID: 26427624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence with statin therapy in secondary prevention of coronary heart disease in veterans administration male population.
    Kopjar B; Sales AE; Piñeros SL; Sun H; Li YF; Hedeen AN
    Am J Cardiol; 2003 Nov; 92(9):1106-8. PubMed ID: 14583366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional and practice variation in adherence to guideline recommendations for secondary and primary prevention among outpatients with atherothrombosis or risk factors in the United States: a report from the REACH Registry.
    Kumar A; Fonarow GC; Eagle KA; Hirsch AT; Califf RM; Alberts MJ; Boden WE; Steg PG; Shao M; Bhatt DL; Cannon CP;
    Crit Pathw Cardiol; 2009 Sep; 8(3):104-11. PubMed ID: 19726929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.